- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02353689
The Effect of FODMAP Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
February 4, 2015 updated by: Oh Yoen Kim
Identification of the Effect of Fermentable Oligo-, di-, and Mono- Saccharides and Poorly Absorbed Short-chain Carbohydrate (FODMAP) Content in Tube Feeding Formula on Feeding Intolerance and Nutritional Status Improvement
This study aimed to investigate the effects of FODMAP contents in enteral nutrition (EN) formulas on major gastrointestinal intolerance symptoms and nutritional status in tube fed patients through the randomized, double blind and placebo-controlled trial.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
A randomized, double-blind, placebo-controlled study was conducted on 100 tube-fed patients.
Over a 14-day test period, the test group consumed EN formula containing low FODMAPs, while the placebo groups consumed EN formula containing moderate or high FODMAPs .
Study Type
Interventional
Enrollment (Actual)
84
Phase
- Phase 2
- Phase 3
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- tube-feeding patients
Exclusion Criteria:
- EN prohibited
- renal dysfunction (i.e. serum creatinine > 1.5 mg/dl or blood urea nitrogen > 25 mg/ml)
- liver dysfunction (i.e. serum aspartate aminotransferase > 40 U/L or alanine aminotransferase > 40 U/L)
- uncontrollable diabetes mellitus
- pregnancy, breast-feeding etc.
- severe diarrhea
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Basic Science
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Quadruple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: low FODMAP group
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
|
consumed EN formula containing low FODMAPs (0.320g/can) during 14-day intervention
|
Experimental: moderate FODMAP group
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
|
consumed EN formula containing moderate FODMAPs (0.753g/can) during 14-day intervention
|
Experimental: high FODMAP group
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
|
consumed EN formula containing high FODMAPs (1.222g/can) during 14-day intervention
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
diarrhea
Time Frame: 14-day follow-up
|
14-day follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
prealbumin
Time Frame: 14-day follow-up
|
14-day follow-up
|
body mass index
Time Frame: 14-day follow-up
|
14-day follow-up
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Oh Yoen Kim, PhD, Dong-A Univeristy
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2013
Primary Completion (Actual)
December 1, 2014
Study Completion (Actual)
December 1, 2014
Study Registration Dates
First Submitted
January 29, 2015
First Submitted That Met QC Criteria
February 2, 2015
First Posted (Estimate)
February 3, 2015
Study Record Updates
Last Update Posted (Estimate)
February 5, 2015
Last Update Submitted That Met QC Criteria
February 4, 2015
Last Verified
February 1, 2015
More Information
Terms related to this study
Other Study ID Numbers
- 2-1040709-AB-N-01-201310-BR-03
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Enteral Nutrition
-
University of MichiganChildren's Mercy Hospital Kansas CityTerminatedEnteral Nutrition | Enteral Feeding | Gastrostomy TubeUnited States
-
Xian-Jun YuNot yet recruitingEnteral NutritionChina
-
The University of Texas Health Science Center at...Not yet recruiting
-
NestléCompletedEnteral NutritionFrance
-
Yonsei UniversityCompletedEnteral Nutrition
-
Fresenius KabiCompleted
-
National Cheng-Kung University HospitalCompleted
-
Children's Hospital of PhiladelphiaEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsActive, not recruiting
-
University of NottinghamKaneka CorporationCompletedEnteral NutritionUnited Kingdom
-
University of British ColumbiaProvidence HealthcareUnknown
Clinical Trials on low FODMAP
-
Vendsyssel HospitalCompleted
-
Ashok TutejaUnited States Department of DefenseUnknown
-
Beth Israel Deaconess Medical CenterEnrolling by invitation
-
Ohio State UniversityCompletedAutism Spectrum DisorderUnited States
-
University of NottinghamKing's College LondonCompletedIrritable Bowel SyndromeUnited Kingdom
-
Taipei Veterans General Hospital, TaiwanNot yet recruitingIrritable Bowel Syndrome
-
Oslo University HospitalActive, not recruitingIrritable Bowel Syndrome | Diet Modification | Celiac Disease | Gluten SensitivityNorway
-
Medical University of WarsawNutricia FoundationUnknown
-
Weizmann Institute of ScienceNot yet recruitingIrritable Bowel Syndrome
-
Cantonal Hospital of St. GallenCompletedIBS - Irritable Bowel Syndrome